Literature DB >> 23002431

Cholangiocarcinoma pathogenesis: Role of the tumor microenvironment.

Dinorah Leyva-Illades, Matthew McMillin, Matthew Quinn, Sharon Demorrow.   

Abstract

Cholangiocarcinoma is a tumor that originates from the neoplastic transformation of the epithelial cells of the intrahepatic or extrahepatic bile ducts. This type of cancer is difficult to diagnose, extremely aggressive, and has very poor prognosis. It is also relatively resistant to chemotherapy and radiation therapy. Its pathogenesis is poorly understood, however it is known that the tumor microenvironment is a very important factor in the regulation of tumor angiogenesis, invasion, and metastasis. The current knowledge about the mechanisms by which these events are regulated as well as the role of the tumor microenvironment in the pathogenesis and classification of cholangiocarcinoma will be discussed.

Entities:  

Year:  2012        PMID: 23002431      PMCID: PMC3448449     

Source DB:  PubMed          Journal:  Transl Gastrointest Cancer        ISSN: 2224-476X


  83 in total

1.  Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways.

Authors:  S Descamps; R A Toillon; E Adriaenssens; V Pawlowski; S M Cool; V Nurcombe; X Le Bourhis; B Boilly; J P Peyrat; H Hondermarck
Journal:  J Biol Chem       Date:  2001-02-28       Impact factor: 5.157

Review 2.  Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment.

Authors:  M F Chen
Journal:  J Gastroenterol Hepatol       Date:  1999-12       Impact factor: 4.029

3.  Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma.

Authors:  Shusaku Ohira; Motoko Sasaki; Kenichi Harada; Yasunori Sato; Yoh Zen; Kumiko Isse; Kazuto Kozaka; Akira Ishikawa; Koji Oda; Yuji Nimura; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

4.  Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma.

Authors:  Horlad Hasita; Yoshihiro Komohara; Hirohisa Okabe; Toshiro Masuda; Koji Ohnishi; Xiao F Lei; Toru Beppu; Hideo Baba; Motohiro Takeya
Journal:  Cancer Sci       Date:  2010-05-12       Impact factor: 6.716

5.  Nerve growth factor-beta expression is associated with lymph node metastasis and nerve infiltration in human hilar cholangiocarcinoma.

Authors:  Lei-Bo Xu; Chao Liu; Guo-Quan Gao; Xian-Huan Yu; Rui Zhang; Jie Wang
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

6.  Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis.

Authors:  Suksanti Prakobwong; Jarinya Khoontawad; Puangrat Yongvanit; Chawalit Pairojkul; Yusuke Hiraku; Paiboon Sithithaworn; Porntip Pinlaor; Bharat B Aggarwal; Somchai Pinlaor
Journal:  Int J Cancer       Date:  2010-11-03       Impact factor: 7.396

7.  Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression.

Authors:  Giammarco Fava; Sharon Demorrow; Eugenio Gaudio; Antonio Franchitto; Paolo Onori; Guido Carpino; Shannon Glaser; Heather Francis; Monique Coufal; Luca Marucci; Domenico Alvaro; Marco Marzioni; Trenton Horst; Romina Mancinelli; Antonio Benedetti; Gianfranco Alpini
Journal:  Liver Int       Date:  2009-03-09       Impact factor: 5.828

8.  Biliary infections: spectrum of imaging findings and management.

Authors:  Onofrio A Catalano; Dushyant V Sahani; David G Forcione; Benedikt Czermak; Chang-Hsien Liu; Andrea Soricelli; Ronald S Arellano; Peter R Muller; Peter F Hahn
Journal:  Radiographics       Date:  2009-11       Impact factor: 5.333

9.  Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Authors:  A F Olumi; G D Grossfeld; S W Hayward; P R Carroll; T D Tlsty; G R Cunha
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

10.  Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma.

Authors:  D Yoshikawa; H Ojima; A Kokubu; T Ochiya; S Kasai; S Hirohashi; T Shibata
Journal:  Br J Cancer       Date:  2009-03-24       Impact factor: 7.640

View more
  28 in total

Review 1.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management.

Authors:  Jesus M Banales; Jose J G Marin; Angela Lamarca; Pedro M Rodrigues; Shahid A Khan; Lewis R Roberts; Vincenzo Cardinale; Guido Carpino; Jesper B Andersen; Chiara Braconi; Diego F Calvisi; Maria J Perugorria; Luca Fabris; Luke Boulter; Rocio I R Macias; Eugenio Gaudio; Domenico Alvaro; Sergio A Gradilone; Mario Strazzabosco; Marco Marzioni; Cédric Coulouarn; Laura Fouassier; Chiara Raggi; Pietro Invernizzi; Joachim C Mertens; Anja Moncsek; Sumera Rizvi; Julie Heimbach; Bas Groot Koerkamp; Jordi Bruix; Alejandro Forner; John Bridgewater; Juan W Valle; Gregory J Gores
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06-30       Impact factor: 46.802

2.  Locoregional therapies in cholangiocarcinoma.

Authors:  Peter L Labib; Brian R Davidson; Ricky A Sharma; Stephen P Pereira
Journal:  Hepat Oncol       Date:  2017-11-17

3.  Glasgow Prognostic Score predicts prognosis of intrahepatic cholangiocarcinoma.

Authors:  Qun-Xiong Pan; Zi-Jian Su; Jian-Hua Zhang; Chong-Ren Wang; Shao-Ying Ke
Journal:  Mol Clin Oncol       Date:  2017-02-16

4.  SLC1A1-mediated cellular and mitochondrial influx of R-2-hydroxyglutarate in vascular endothelial cells promotes tumor angiogenesis in IDH1-mutant solid tumors.

Authors:  Xiaomin Wang; Ziqi Chen; Jun Xu; Shuai Tang; Nan An; Lei Jiang; Yixiang Zhang; Shaoying Zhang; Qingli Zhang; Yanyan Shen; Shijie Chen; Xiaojing Lan; Ting Wang; Linhui Zhai; Siyuwei Cao; Siqi Guo; Yingluo Liu; Aiwei Bi; Yuehong Chen; Xiameng Gai; Yichen Duan; Ying Zheng; Yixian Fu; Yize Li; Liang Yuan; Linjiang Tong; Kun Mo; Mingcheng Wang; Shu-Hai Lin; Minjia Tan; Cheng Luo; Yi Chen; Jia Liu; Qiansen Zhang; Leping Li; Min Huang
Journal:  Cell Res       Date:  2022-04-22       Impact factor: 46.297

Review 5.  Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview.

Authors:  Simone Brivio; Massimiliano Cadamuro; Luca Fabris; Mario Strazzabosco
Journal:  Gene Expr       Date:  2017-10-25

Review 6.  The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.

Authors:  Silvia Affo; Le-Xing Yu; Robert F Schwabe
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

7.  Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies.

Authors:  Massimiliano Cadamuro; Stuart Duncan Morton; Mario Strazzabosco; Luca Fabris
Journal:  Transl Gastrointest Cancer       Date:  2013-07

Review 8.  Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.

Authors:  Alphonse E Sirica; Mario Strazzabosco; Massimiliano Cadamuro
Journal:  Adv Cancer Res       Date:  2020-12-09       Impact factor: 6.242

9.  Inhibition of Mast Cell-Derived Histamine Decreases Human Cholangiocarcinoma Growth and Differentiation via c-Kit/Stem Cell Factor-Dependent Signaling.

Authors:  Christopher Johnson; Victoria Huynh; Laura Hargrove; Lindsey Kennedy; Allyson Graf-Eaton; Jennifer Owens; Jerome P Trzeciakowski; Kyle Hodges; Sharon DeMorrow; Yuyan Han; Lucas Wong; Gianfranco Alpini; Heather Francis
Journal:  Am J Pathol       Date:  2015-11-18       Impact factor: 4.307

10.  JNK contributes to the tumorigenic potential of human cholangiocarcinoma cells through the mTOR pathway regulated GRP78 induction.

Authors:  Chunhong Feng; Kai He; Chunyan Zhang; Song Su; Bo Li; Yuxiao Li; Chun-Yan Duan; Shaokun Chen; Run Chen; Youping Liu; Hong Li; Mei Wei; Xianming Xia; Rongyang Dai
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.